Active Stocks
Mon Jun 30 2025 14:02:25
  1. Tata Steel share price
  2. 160.00 -0.87%
  1. Tata Motors share price
  2. 688.75 0.30%
  1. State Bank Of India share price
  2. 817.25 1.47%
  1. Reliance Industries share price
  2. 1,499.00 -1.12%
  1. Ntpc share price
  2. 334.00 -1.17%
Business News/Market/Market Stats/    Tatva Chintan Pharma Chem

TATVA CHINTAN PHARMA CHEM SUMMARY

Tatva Chintan Pharma Chem is trading 0.82% upper at Rs 950.75 as compared to its last closing price. Tatva Chintan Pharma Chem has been trading in the price range of 964.40 & 930. Tatva Chintan Pharma Chem has given 6.04% in this year & 2.82% in the last 5 days.

 

Tatva Chintan Pharma Chem has TTM P/E ratio 277.52 as compared to the sector P/E of 17.69. There are 5 analysts who have initiated coverage on Tatva Chintan Pharma Chem. There are 2 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 1.03 Crores in its last quarter.

 

Listed peers of Tatva Chintan Pharma Chem include Meghmani Organics (1.51%), Dcw (0.32%), Tatva Chintan Pharma Chem (0.82%) etc.

 

Tatva Chintan Pharma Chem has a 72.02% promoter holding & 27.98% public holding.

FAQs about Tatva Chintan Pharma Chem

Tatva Chintan Pharma Chem is trading at 950.75 as on 30 Jun, 2025 1:42:38 PM. This is 0.82% upper as compared to its previous closing price of 943
The market capitalization of Tatva Chintan Pharma Chem is 2227.63 Cr as on 30 Jun, 2025 1:42:38 PM.
The average broker rating on Tatva Chintan Pharma Chem is Buy. The breakup of analyst rating is given below -
  • 1 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 1 analysts have given a hold rating
  • 1 analysts have given a buy rating
  • 2 analysts have given a strong buy rating
The 52 wk high for Tatva Chintan Pharma Chem is 1195.05 whereas the 52 wk low is 610
Tatva Chintan Pharma Chem can be analyzed on the following key metrics -
  • TTM P/E: 277.52
  • Sector P/E: 17.69
  • Dividend Yield: 0.11%
  • D/E ratio: -
Tatva Chintan Pharma Chem reported a net profit of 5.71 Cr in 2025.
Recommended For You